RECENTLY intravenous diazepam (Valium) has been reported to be extremely effective in controlling "status epilepticus," 1–6 or what we prefer to call prolonged seizure activity. Both Gastaut et al. 1 ...
CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable ...
Xeris Pharmaceuticals last year snared approval for its first drug, a shelf-stable glucagon injector for hypoglycemia. Now it's deploying its formulation tech to hit another target—epilepsy—and the ...
CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable ...
CHICAGO--(BUSINESS WIRE)-- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation platforms to develop and commercialize ready-to-use ...
Treatment with diazepam nasal spray resulted in a statistically significant change in time between seizure clusters, potentially reflecting a beneficial effect of intermittent rescue therapy. New post ...
Diazepam 5mg/mL; soln for IM or IV use; contains propylene glycol 40%, ethyl and benzyl alcohol. Diazepam is a benzodiazepine that exerts anxiolytic, sedative, muscle-relaxant, anticonvulsant and ...
BALTIMORE -- Diazepam nasal spray (Valtoco; NRL-1), an investigational rescue medicine for epilepsy patients with seizure clusters or acute repetitive seizures, had high bioavailability and was ...
In this younger patient population, diazepam nasal spray was readily absorbed and demonstrated a consistent PK profile with that of older children and adults aged 6 to 59 years. The Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results